National Institute for Health and Care Excellence: Standards

(asked on 8th February 2022) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what steps they are taking to support patients to access (1) new, and (2) cost-effective, medicinesĀ as quickly as possible through robust oversight of the National Institute for Health and Care Excellence (NICE) processes.


Answered by
Lord Kamall Portrait
Lord Kamall
This question was answered on 15th February 2022

The Department holds regular accountability meetings with the National Institute for Health and Care Excellence (NICE) to review performance against its priorities and objectives, including consideration of any capacity issues. No current capacity issues have been identified. NICE will focus on key priorities, such as addressing health inequalities, providing recommendations where its guidance will have the greatest impact. NICE has recently completed a review of the methods and processes for evaluating clinically and cost-effective health technologies to ensure rapid access for patients, the National Health Service and the life sciences industry. This review will enable NICE to be faster, flexible, more responsive and transparent in supporting the health and care system and the life sciences industry and allow new and emerging health technologies to be available patients as soon as possible.

Reticulating Splines